Media Room
Year-End Late-Stage Pipeline Review
Sanofi is pleased to invite investors and analysts to participate in a year-end late-stage pipeline review by R&D management on Tuesday, December 16, 2025.
Press releases
December 15, 2025
Press Release: Sanofi provides update on tolebrutinib in primary progressive multiple sclerosis
December 15, 2025
Press Release : Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
December 11, 2025
Press Release: Sanofi’s Qfitlia and Cablivi approved in China, expanding care for rare diseases
Contact Our Media Team
You are a journalist and have a question about Sanofi, please contact the Global Media relations team. Please note the contact details are only for journalists.
Publications
Half year 2025 financial report XBRL package
Half Year 2025 Financial Report
Sustainability Statement 2024 (ESG Report)
Registration Document 2024 (in French)